Show simple item record

HLA-DRB1*15 and pediatric aplastic anemia

dc.contributor.authorDiler, AS
dc.contributor.authorDorak, MT
dc.contributor.authorYalman, N
dc.contributor.authorOguz, R
dc.contributor.authorAnak, S
dc.contributor.authorOguz, FS
dc.date.accessioned2021-03-03T18:44:25Z
dc.date.available2021-03-03T18:44:25Z
dc.date.issued2002
dc.identifier.citationOguz F., Yalman N., Diler A., Oguz R., Anak S., Dorak M., "HLA-DRB1*15 and pediatric aplastic anemia", HAEMATOLOGICA, cilt.87, sa.7, ss.772-774, 2002
dc.identifier.issn0390-6078
dc.identifier.othervv_1032021
dc.identifier.otherav_50c5581c-c2e7-4e25-a1a3-35316c453cca
dc.identifier.urihttp://hdl.handle.net/20.500.12627/57482
dc.description.abstractWe report a positive association between HLA-DRB1*15 (p = 0.0002) in Turkish patients with pediatric severe aplastic anemia (SAA) and a paradoxically favorable influence of the susceptibility marker on the clinical response to immunosuppressive therapy. These findings point to an immune mechanism mediated by DRB1*15 in SAA which confers responsiveness to treatment.
dc.language.isoeng
dc.subjectHematoloji
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleHLA-DRB1*15 and pediatric aplastic anemia
dc.typeMakale
dc.relation.journalHAEMATOLOGICA
dc.contributor.department, ,
dc.identifier.volume87
dc.identifier.issue7
dc.identifier.startpage772
dc.identifier.endpage774
dc.contributor.firstauthorID165473


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record